GiantFamily

I LOVE PIXEL ART 👾

Natively-intelligent machines were first shared with the world by $CPHY.

🚨BREAKING: Microsoft just canceled its Claude Code licenses. Not because the tool didn't work. Not because developers didn't love it. Because the bill was too high to justify. Let that sink in. The same company that invested $13 billion into OpenAI. The same company that owns the cloud powering most of AI today. Looked at the bill and said no. If Microsoft can't afford it, what does that mean for you? Here is what is happening right now: → Uber burned its entire 2026 AI budget in just 4 months → AI software prices jumped 20% to 37% overnight → GitHub killed flat-rate plans; usage-based billing is now the standard → Anthropic, OpenAI & Google all raised prices in the last 6 months → Enterprise budgets built on cheap AI are collapsing in real time This is not a small correction. This is the end of the AI subsidy era. For 3 years, labs burned billions to keep prices low. They needed your adoption. They needed your data. They needed your case studies. You were not the customer. You were the experiment. Now the experiment is over. Two roads ahead both lead to the same cliff: Road 1: → Enterprises cut AI usage to fit budgets → Revenue slows → Valuations collapse before IPO Road 2: → Labs cut prices to keep customers → Unit economics break → Someone takes the write-down There is no third option. The numbers stop working. Somebody pays. The AI boom was real. The pricing was not. Companies that built their 2026 strategy around falling AI costs? They are already behind. ♻️ Repost Every founder, investor & CTO needs this today. Full breakdown link in Comment

🚨BREAKING: Microsoft just canceled its Claude Code licenses. Not because the tool didn't work. Not because developers didn't love it. Because the bill was too high to justify. Let that sink in. The same company that invested $13 billion into OpenAI. The same company that owns the cloud powering most of AI today. Looked at the bill and said no. If Microsoft can't afford it, what does that mean for you? Here is what is happening right now: → Uber burned its entire 2026 AI budget in just 4 months → AI software prices jumped 20% to 37% overnight → GitHub killed flat-rate plans; usage-based billing is now the standard → Anthropic, OpenAI & Google all raised prices in the last 6 months → Enterprise budgets built on cheap AI are collapsing in real time This is not a small correction. This is the end of the AI subsidy era. For 3 years, labs burned billions to keep prices low. They needed your adoption. They needed your data. They needed your case studies. You were not the customer. You were the experiment. Now the experiment is over. Two roads ahead both lead to the same cliff: Road 1: → Enterprises cut AI usage to fit budgets → Revenue slows → Valuations collapse before IPO Road 2: → Labs cut prices to keep customers → Unit economics break → Someone takes the write-down There is no third option. The numbers stop working. Somebody pays. The AI boom was real. The pricing was not. Companies that built their 2026 strategy around falling AI costs? They are already behind. ♻️ Repost Every founder, investor & CTO needs this today. Full breakdown link in Comment

Scientists created a revolutionary "liquid spine" injection that can regenerate damaged disks. And it could end the need for invasive back surgeries by healing the problem from the inside out. Medical science is shifting from simply managing chronic spinal pain to actively reversing it through advanced, injectable hydrogels. These biocompatible materials are designed to mimic the natural gel-like center of spinal discs, providing immediate mechanical support and restoring lost disc height through a minimally invasive needle procedure. Unlike traditional treatments that rely on masking symptoms or performing risky surgeries, this approach targets the physical decay of the disc itself, filling structural gaps and re-establishing a healthy environment within the spine. Beyond structural stability, these hydrogels act as high-tech scaffolds that deliver stem cells and growth factors directly to the site of injury. By inhibiting inflammatory enzymes and stimulating natural cellular repair, the treatment encourages the body to rebuild damaged tissue from within. Early clinical research shows that patients experience substantial pain relief and improved mobility, potentially eliminating the requirement for invasive spinal fusion surgeries. By restoring hydration and biological function, this therapy offers a long-term path to recovery for millions of people living with Degenerative Disc Disease. source: Li, Z., Mao, H., & Wang, J. Injectable Hydrogels for Intervertebral Disc Regeneration: A Review of Current Materials and Strategies. Journal of Biomedical Materials Research Part A.